FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W954995153> ?p ?o ?g. }

• W954995153 abstract "Abstract Background Pediatric precursor B-cell acute lymphoblastic leukemia (BCP-ALL) with the BCR-ABL1 translocation forms a small group with a poor prognosis. Approximately 15% of BCP-ALL cases are characterized by a gene expression signature similar to BCR-ABL1-positive disease. This so-called BCR-ABL1-like group shares the poor prognosis of the BCR-ABL1-positive subtype but without presence of a BCR-ABL1 translocation. Using different cohorts and methods, two different BCR-ABL1-like signatures have been identified (Den Boer et al., Lancet Oncol 2009; Mullighan et al., New Engl J Med 2009). Both signatures identify groups of patients with a poor prognosis and with deletions in B-cell development genes (Den Boer et al., Lancet Oncol 2009; Roberts et al., Cancer Cell 2012). The aim of this study was to compare these two signatures and the association to molecular aberrations and clinical outcome in diagnostic samples of the Dutch Childhood Oncology Group (DCOG) and the German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia (COALL). Patients and methods The BCP-ALL study cohort consisted of 452 patients, including 146 patients with B-precursor ALL without known recurrent aberrations (BCR-ABL1 translocation, ETV6-RUNX1 translocation, MLL rearrangements, TCF3 rearrangements, hyperdiploidy). BCR-ABL1-like cases were identified in these 146 B-precursor cases using Prediction Analysis of Microarrays (PAM) with 257 probe sets (Roberts et al., Cancer Cell 2012) and separately by Hierarchical Clustering (HC) with 110 probe sets (Den Boer et al., Lancet Oncol 2009), using Affymetrix U133Plus2 expression data. Frequencies of molecular aberrations detected by multiplex ligation-dependent probe amplification, array-comparative genomic hybridization and Sanger sequencing, including IKZF1 deletions, JAK2 mutations and CRLF2 aberrations, were compared between groups of patient samples classified by the two prediction algorithms using Fisher's Exact test. We analyzed the cumulative incidence of relapse (CIR) with death as a competing event. Results In the DCOG/COALL cohort, which included patients from all ALL risk groups, we identified 33 BCR-ABL1-like cases with the PAM signature, of which 24 (73%) were high-risk according to the NCI-Rome criteria (WBC ≥ 50 cells/nl and/or age ≥ 10 years), and 79 cases with the HC signature, of which 57 (72%) were high-risk. Compared with 59 B-other cases not identified by either of the two BCR-ABL1-like signatures, the most enriched molecular aberrations in the PAM-identified group were IKZF1 deletions (52% vs 19%, p=0.002), high CRLF2 expression (39% vs 8%, p<0.001), intrachromosomal amplification of chromosome 21 (iAMP21; 32% vs 0%, p<0.0001), and RB1 deletions (23% vs 6%, p=0.04). Enriched aberrations in the HC-identified group included IKZF1 deletions (38% vs 19%, p=0.02), dic(9;20) (28% vs 4%, p<0.001), and iAMP21 (15% vs 0%, p=0.002), while BTG1 deletions occurred less frequently (6% vs 17%, p=0.04). Directly comparing PAM and HC-identified BCR-ABL-like cases indicated significantly higher proportions of CRLF2-high (p=0.004) and JAK2 mutations (p=0.02) in the PAM group, and higher dic(9;20) in the HC group (p=0.03). Next, we compared the overlap between cases identified by the two signatures. PAM identified 32% (25/79) of the BCR-ABL1-like cases identified by HC, and vice versa HC identified 76% (25/33) of the cases identified by PAM. The cumulative incidence of relapse at 5-years in the BCR-ABL1-like groups identified by PAM (20%, p=0.04), HC (27%, p<0.0001), or both methods (18%, p=0.15), was worse than in the non-BCR-ABL1-like/BCR-ABL1-negative/MLL wild-type BCP-ALL reference group (8.1%). Cases identified only by HC (31%, p<0.0001) or only by PAM (25%, p=0.05) also had higher 5-year cumulative relapse incidences than the reference group. Conclusions Both BCR-ABL1-like expression signatures defined by HC or PAM identified a group of patients with an unfavorable prognosis in the DCOG/COALL study. The two groups largely overlapped, but each signature also identified unique patients not identified by the other signature. Importantly, each of the signatures was associated with poor outcome, while patients identified by both signatures (PAM/HC-double positive) did not have a worse outcome than those identified only by PAM or HC. Since the two signatures are partially complementary, we suggest that both should be used. Disclosures: Evans: St. Jude: In accordance with institutional policy, St. Jude allocates a portion of the income it receives from licensing inventions and tangible research materials to those researchers responsible for creating this intellectual property., In accordance with institutional policy, St. Jude allocates a portion of the income it receives from licensing inventions and tangible research materials to those researchers responsible for creating this intellectual property. Patents & Royalties, Under this policy, I and/or my spouse have in the past received a portion of the income St. Jude receives from licensing patent rights related to TPMT polymorphisms as clinical diagnostics. Other." @default.
• W954995153 created "2016-06-24" @default.
• W954995153 creator A5022986622 @default.
• W954995153 creator A5024275910 @default.
• W954995153 creator A5034189317 @default.
• W954995153 creator A5035292815 @default.
• W954995153 creator A5036952273 @default.
• W954995153 creator A5082829887 @default.
• W954995153 date "2013-11-15" @default.
• W954995153 modified "2023-09-26" @default.
• W954995153 title "BCR-ABL1-Like Cases In Pediatric Acute Lymphoblastic Leukemia: A Comparison Between COG/St. Jude and Dutch DCOG Signatures" @default.
• W954995153 doi "https://doi.org/10.1182/blood.v122.21.2633.2633" @default.
• W954995153 hasPublicationYear "2013" @default.
• W954995153 type Work @default.
• W954995153 sameAs 954995153 @default.
• W954995153 citedByCount "1" @default.
• W954995153 countsByYear W9549951532016 @default.
• W954995153 crossrefType "journal-article" @default.
• W954995153 hasAuthorship W954995153A5022986622 @default.
• W954995153 hasAuthorship W954995153A5024275910 @default.
• W954995153 hasAuthorship W954995153A5034189317 @default.
• W954995153 hasAuthorship W954995153A5035292815 @default.
• W954995153 hasAuthorship W954995153A5036952273 @default.
• W954995153 hasAuthorship W954995153A5082829887 @default.
• W954995153 hasConcept C104317684 @default.
• W954995153 hasConcept C121608353 @default.
• W954995153 hasConcept C126322002 @default.
• W954995153 hasConcept C138626823 @default.
• W954995153 hasConcept C143998085 @default.
• W954995153 hasConcept C170493617 @default.
• W954995153 hasConcept C2778461978 @default.
• W954995153 hasConcept C2781107101 @default.
• W954995153 hasConcept C2909962599 @default.
• W954995153 hasConcept C43907098 @default.
• W954995153 hasConcept C502942594 @default.
• W954995153 hasConcept C54355233 @default.
• W954995153 hasConcept C71924100 @default.
• W954995153 hasConcept C86803240 @default.
• W954995153 hasConceptScore W954995153C104317684 @default.
• W954995153 hasConceptScore W954995153C121608353 @default.
• W954995153 hasConceptScore W954995153C126322002 @default.
• W954995153 hasConceptScore W954995153C138626823 @default.
• W954995153 hasConceptScore W954995153C143998085 @default.
• W954995153 hasConceptScore W954995153C170493617 @default.
• W954995153 hasConceptScore W954995153C2778461978 @default.
• W954995153 hasConceptScore W954995153C2781107101 @default.
• W954995153 hasConceptScore W954995153C2909962599 @default.
• W954995153 hasConceptScore W954995153C43907098 @default.
• W954995153 hasConceptScore W954995153C502942594 @default.
• W954995153 hasConceptScore W954995153C54355233 @default.
• W954995153 hasConceptScore W954995153C71924100 @default.
• W954995153 hasConceptScore W954995153C86803240 @default.
• W954995153 hasLocation W9549951531 @default.
• W954995153 hasOpenAccess W954995153 @default.
• W954995153 hasPrimaryLocation W9549951531 @default.
• W954995153 hasRelatedWork W1185577416 @default.
• W954995153 hasRelatedWork W1951609347 @default.
• W954995153 hasRelatedWork W2075043727 @default.
• W954995153 hasRelatedWork W2301731709 @default.
• W954995153 hasRelatedWork W2544866590 @default.
• W954995153 hasRelatedWork W2551525153 @default.
• W954995153 hasRelatedWork W2553755930 @default.
• W954995153 hasRelatedWork W2564019916 @default.
• W954995153 hasRelatedWork W2565885331 @default.
• W954995153 hasRelatedWork W2593304307 @default.
• W954995153 hasRelatedWork W2610575331 @default.
• W954995153 hasRelatedWork W2622722746 @default.
• W954995153 hasRelatedWork W2763797335 @default.
• W954995153 hasRelatedWork W2979984567 @default.
• W954995153 hasRelatedWork W2980048495 @default.
• W954995153 hasRelatedWork W2981142449 @default.
• W954995153 hasRelatedWork W2987397077 @default.
• W954995153 hasRelatedWork W2991937836 @default.
• W954995153 hasRelatedWork W3022034572 @default.
• W954995153 hasRelatedWork W3034026050 @default.
• W954995153 isParatext "false" @default.
• W954995153 isRetracted "false" @default.
• W954995153 magId "954995153" @default.
• W954995153 workType "article" @default.